DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
McDermott DF, Motzer RJ, Atkins MB. et al.
Long-term overall survival with nivolumab in previously treated patients with advanced renal cell carcinoma (aRCC) from phase I and II studies.
J Clin Oncol 2016; (suppl; abstr 4507)
34: 4507-4507
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.